To compare potential biologic markers with laboratory, clinical and histopathologic parameters and PSA level, tumour stage, tumour grade, and DNA content, Papadopoulos et al [103] characterized the proliferation marker Ki-S5, p53 expression, and ploidy status as potential tumour biomarkers. Here, KLK3 is linked to neoplasm.